Robinson Value Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.03M Sell
51,525
-1,252
-2% -$101K 2.16% 15
2026
Q1
$4.57M Sell
52,777
-1,102
-2% -$106K 2.55% 10
2025
Q4
$5.18M Sell
53,879
-519
-1% -$50.4K 2.8% 7
2025
Q3
$5.18M Buy
54,398
+458
+0.8% +$42.1K 3% 6
2025
Q2
$4.7M Sell
53,940
-378
-0.7% -$32.1K 2.95% 7
2025
Q1
$4.88M Sell
54,318
-390
-0.7% -$34.9K 3.15% 5
2024
Q4
$4.37M Buy
54,708
+657
+1% +$56.9K 2.89% 6
2024
Q3
$4.87M Buy
54,051
+1,066
+2% +$89.7K 3.16% 8
2024
Q2
$4.17M Sell
52,985
-189
-0.4% -$15.5K 2.91% 8
2024
Q1
$4.63M Buy
53,174
+28,059
+112% +$2.39M 3.11% 7
2023
Q4
$2.07M Hold
25,115
1.36% 30
2023
Q3
$1.97M Buy
25,115
+126
+0.5% +$10.5K 1.47% 27
2023
Q2
$2.2M Buy
24,989
+421
+2% +$36.2K 1.59% 27
2023
Q1
$1.98M Sell
24,568
-63
-0.3% -$5.13K 1.52% 30
2022
Q4
$1.91M Buy
+24,631
New +$2M 1.65% 29

Other funds holding MDT

Robinson Value Management's MDT Position: Q2 2026 in Review

Robinson Value Management reduced its Medtronic (MDT) stake by 2.4% in Q2 2026, selling an estimated $101K and leaving 51,525 shares worth $4.03M. The position accounts for 2.16% of the portfolio, ranked #15.

Robinson Value Management first reported a position in MDT in Q4 2022 and has held it in 15 quarters since. The position peaked at $5.18M in Q3 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Robinson Value Management held 51,525 shares of Medtronic worth $4.03M as of Q2 2026.
  • Robinson Value Management sold 1,252 Medtronic shares in Q2 2026, an estimated $101K.
  • Medtronic made up 2.16% of Robinson Value Management's portfolio in Q2 2026, its #15 holding.
  • Robinson Value Management first reported a position in Medtronic in Q4 2022 and has held it in 15 quarters since.
  • Robinson Value Management's Medtronic position peaked at $5.18M in Q3 2025.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Robinson Value Management's 13F filing for Q2 2026, filed 10 Aug 2026.